Novel PARP1 Inhibitor Shows Promise in Breast Cancer : compa

The drug had favorable safety compared with first-generation PARP inhibitors in phase I/II study

Related Keywords

United States , Houston , Texas , Connecticut , Massachusetts , New Haven , American , Mike Bassett , Timothy Yap , Patricia Lorusso , American Association For Cancer Research , Yale School Of Medicine , University Of Texas Md Anderson Cancer Center , Cancer Center , American Association , Cancer Research , Yale School ,